Kennedy R. Lees
University of Glasgow
467 Papers
3.9K Citations
Kennedy R. Lees is an academic researcher from University of Glasgow. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 86, co-authored 455 publications. Previous affiliations of Kennedy R. Lees include Ludwig Maximilian University of Munich & Cedars-Sinai Medical Center.
Chat about Author
Papers
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study
Maurizio Paciaroni,Giancarlo Agnelli,Nicola Falocci,Valeria Caso,Cecilia Becattini,Simona Marcheselli,Christina Rueckert,Alessandro Pezzini,Loris Poli,Alessandro Padovani,László Csiba,Lilla Szabó,Sung Il Sohn,Tiziana Tassinari,Azmil H. Abdul-Rahim,Patrik Michel,Maria Cordier,Peter Vanacker,Suzette Remillard,Andrea Alberti,Michele Venti,Monica Acciarresi,Cataldo D'Amore,Maria Giulia Mosconi,Umberto Scoditti,Licia Denti,Giovanni Orlandi,Alberto Chiti,Gino Gialdini,Paolo Bovi,Monica Carletti,Alberto Rigatelli,Jukka Putaala,Turgut Tatlisumak,Turgut Tatlisumak,Luca Masotti,Gianni Lorenzini,Rossana Tassi,Francesca Guideri,Giuseppe Martini,Georgios Tsivgoulis,Georgios Tsivgoulis,Kostantinos Vadikolias,Chrissoula Liantinioti,Francesco Corea,Massimo Del Sette,Walter Ageno,Maria Luisa De Lodovici,Giorgio Bono,Antonio Baldi,Sebastiano D'Anna,Simona Sacco,Antonio Carolei,Cindy Tiseo,Davide Imberti,Dorjan Zabzuni,Boris Doronin,Vera Volodina,Domenico Consoli,Franco Galati,Alessio Pieroni,Danilo Toni,Serena Monaco,Mario Maimone Baronello,Kristian Barlinn,Lars-Peder Pallesen,Jessica Kepplinger,Ulf Bodechtel,Johannes Gerber,Dirk Deleu,Gayane Melikyan,Faisal Ibrahim,Naveed Akhtar,Kennedy R. Lees +73 more
TL;DR: Evaluated in patients with acute ischemic stroke and AF the association between findings at trans-thoracic echocardiography (TTE) and 90 days recurrence, finding left atrial enlargement is an independent marker of recurrent stroke and systemic embolism.
Additional Outcomes and Subgroup Analyses of NXY-059 for Acute Ischemic Stroke in the SAINT I Trial
Kennedy R. Lees,Antonio Dávalos,Stephen M. Davis,Hans-Christoph Diener,James C. Grotta,Patrick D. Lyden,Ashfaq Shuaib,Tim Ashwood,Hans-Göran Hårdemark,Warren W. Wasiewski,Ugochi Emeribe,Justin A. Zivin +11 more
TL;DR: NXY-059 within 6 hours of acute ischemic stroke significantly reduced disability and was detectable early but not significant at 90 days; however, the trial was underpowered to measure effects on the neurological examination.
Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes.
Fozia S Nazir,M. Alem,Michael Small,Jmc Connell,Kennedy R. Lees,Matthew Walters,S. J. Cleland +6 more
TL;DR: The effect of diabetes on basal cerebrovascular endothelial function as assessed by response to the nitric oxide synthase (NOS) inhibitor NG‐monomethyl‐l‐arginine (l‐NMMA) is investigated.
Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists
Richard Tran,Alastair J Rankin,Azmil H. Abdul-Rahim,Gregory Y.H. Lip,Andrew C. Rankin,Kennedy R. Lees +5 more
TL;DR: Stroke physicians and cardiologists differ in their diagnosis and management of patients with short runs of atrial arrhythmia within Europe, creating a dilemma for physicians across Europe.
Acute treatment of ischaemic stroke. European Stroke Initiative
TL;DR: Treatment of acute ischaemic stroke remains essential in order to improve outcome and to lower mortality, and there are 5 main areas in the treatment of acute stroke, including neuroprotection, prophylaxis and treatment of complications.